Medical Care Technologies, Inc. (OTC Pink:MDCE) Completes First AI Consumer App Targeting Deployment Across 100+ Countries and 30 Languages

Rhea-AI Summary

Medical Care Technologies (OTC Pink: MDCE) completed its first AI-based consumer application, a dietary and nutrition app the company says will be deployed in 100+ countries and made available in 30+ languages. The app enters iOS testing followed by Google Play testing, a process expected to take weeks, with a coordinated marketing launch and name announcement planned after testing.

The company says this consumer launch complements ongoing development of an AI-driven melanoma detection application, whose coding has reached a milestone and whose launch details will be announced later.

News Market Reaction – MDCE

+25.00%

1 alert

+25.00% News Effect

On the day this news was published, MDCE gained 25.00%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Company to Launch AI Food & Recipe App to Access Trillion-Dollar Global Food Market While Advancing Medical AI Pipeline

MESA, ARIZONA / ACCESS Newswire / December 15, 2025 / Medical Care Technologies, Inc. (OTC Pink:MDCE) today announced the completion of its first AI-based consumer application, marking a major milestone in the Company's strategy to build scalable, revenue-generating artificial intelligence platforms while continuing development of advanced medical AI solutions.

The newly completed application is designed for broad consumer adoption and global reach. The app is expected to be deployed in over 100 countries and made available in more than 30 languages, positioning it as a potential high-impact revenue driver for the Company.

"We decided to launch this application first because it offers the greatest consumer reach," said Marshall Perkins, CEO of Medical Care Technologies, Inc. "This is an app that can be used by most people around the world. We believe consumer-facing AI applications like this can become significant revenue drivers over time, while also laying the groundwork for the future AI platforms we are developing."

The initial launch focuses on a dietary and nutrition-based AI application, targeting a multi-billion-dollar global market. The app leverages artificial intelligence to deliver personalized dietary functionality to users in a unique fashion, supporting the Company's broader vision of building accessible, scalable AI solutions.

Importantly, the Company emphasized that this consumer launch does not detract from its core medical initiatives.

"While we are launching a consumer dietary app first due to its market size and adoption potential, we are not losing focus on our medical determinations," Perkins added. "We have also reached a significant milestone in the coding development of our first AI-driven melanoma detection application."

The melanoma detection application is currently under development, with its name and official launch details to be announced in the coming months.

The newly completed consumer app is now entering iOS testing, followed by submission for Google Play Store testing, a process that is expected to take weeks. Upon completion of testing, the Company plans to initiate a coordinated marketing rally and public launch when the name will be announced.

Medical Care Technologies views this milestone as a foundational step in building a diversified AI ecosystem that spans both consumer wellness and advanced medical technology.

About Medical Care Technologies, Inc.

Medical Care Technologies, Inc. (OTC Pink:MDCE) is a technology company focused on developing and commercializing artificial intelligence solutions across consumer wellness and medical applications. The Company's strategy centers on creating scalable AI platforms that generate revenue while advancing next-generation healthcare technologies, including diagnostic and medical-imaging-based solutions.

For more information, visit www.medicalcaretechnologies.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expected app deployment, market reach, revenue potential, testing timelines, future launches, and ongoing development of medical AI applications. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Factors that may affect results include, but are not limited to, regulatory approvals, market acceptance, competition, development timelines, and general economic conditions. Medical Care Technologies, Inc. undertakes no obligation to update any forward-looking statements except as required by law.

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)

View the original press release on ACCESS Newswire

FAQ

What did Medical Care Technologies announce about its new AI app (MDCE) on December 15, 2025?

The company completed a consumer AI dietary app intended for deployment in 100+ countries and in 30+ languages, and began iOS testing ahead of Google Play testing.

When will Medical Care Technologies (MDCE) launch the new AI food and recipe app?

The company expects testing to take weeks and plans a coordinated public launch and name announcement after testing completion.

How widely will the MDCE consumer app be available at launch?

The company plans to make the app available in over 100 countries and in more than 30 languages.

Does the MDCE consumer app affect Medical Care Technologies' medical AI projects?

The company said the consumer launch does not detract from core medical initiatives and that development continues on an AI-driven melanoma detection application.

What is the status of the MDCE melanoma detection application mentioned in the announcement?

The company reported a coding milestone for its first AI-driven melanoma detection application and said the name and launch details will be announced in coming months.

Where will users be able to access the new Medical Care Technologies (MDCE) app?

The app is entering iOS testing first, then will be submitted for Google Play Store testing prior to public release.